The European database of reported Covid “vaccine” adverse reactions shows 48,817 deaths, 5,107,883 health injuries of which 2,261,134 are serious. Keep in mind that only a small percentage of adverse reactions are reported. Many adverse reactions are attributed to other causes or misdiagnosed as Covid.
- COVID-19 MRNA VACCINE MODERNA (CX-024414)
- COVID-19 MRNA VACCINE PFIZER-BIONTECH
- COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
- COVID-19 VACCINE JANSSEN (AD26.COV2.S)
From the total of injuries recorded, almost half of them (2,177,286) are serious injuries.
“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*
Here is the summary data through November 12, 2022.
Total reactions for the mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer – 23,210 deaths and 2,667,243 injuries to 12/11/2022:
- 79,297 Blood and lymphatic system disorders incl. 335 deaths
- 90,887 Cardiac disorders incl. 3,351 deaths
- 842 Congenital, familial and genetic disorders incl. 66 deaths
- 33,754 Ear and labyrinth disorders incl. 22 deaths
- 3,497 Endocrine disorders incl. 13 deaths
- 38,206 Eye disorders incl. 64 deaths
- 184,670 Gastrointestinal disorders incl. 915 deaths
- 688,114 General disorders and administration site conditions incl. 6,286 deaths
- 3,020 Hepatobiliary disorders incl. 133 deaths
- 28,472 Immune system disorders incl. 156 deaths
- 183,898 Infections and infestations incl. 2,392 deaths
- 46,012 Injury, poisoning and procedural complications incl. 551 deaths
- 63,046 Investigations incl. 630 deaths
- 16,685 Metabolism and nutrition disorders incl. 406 deaths
- 298,841 Musculoskeletal and connective tissue disorders incl. 331 deaths
- 3,302 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 301 deaths
- 407,210 Nervous system disorders incl. 2,482 deaths
- 3,515 Pregnancy, puerperium and perinatal conditions incl. 83 deaths
- 342 Product issues incl. 4 deaths
- 46,792 Psychiatric disorders incl. 267 deaths
- 9,544 Renal and urinary disorders incl. 352 deaths
- 117,187 Reproductive system and breast disorders incl. 11 deaths
- 107,494 Respiratory, thoracic and mediastinal disorders incl. 2,481 deaths
- 117,035 Skin and subcutaneous tissue disorders incl. 207 deaths
- 7,110 Social circumstances incl. 30 deaths
- 29,524 Surgical and medical procedures incl. 309 deaths
- 58,947 Vascular disorders incl. 1,032 deaths
Total reactions for the mRNA vaccine SPIKEVAX/mRNA-1273(CX-024414) from Moderna – 12,703 deaths and 870,106 injuries to 12/11/2022:
- 23,093 Blood and lymphatic system disorders incl. 152 deaths
- 30,044 Cardiac disorders incl. 1,415 deaths
- 269 Congenital, familial and genetic disorders incl. 16 deaths
- 10,043 Ear and labyrinth disorders incl. 8 deaths
- 951 Endocrine disorders incl. 6 deaths
- 11,407 Eye disorders incl. 42 deaths
- 67,342 Gastrointestinal disorders incl. 487 deaths
- 229,166 General disorders and administration site conditions incl. 4,057 deaths
- 1,148 Hepatobiliary disorders incl. 69 deaths
- 9,547 Immune system disorders incl. 46 deaths
- 38,244 Infections and infestations incl. 1,153 deaths
- 12,405 Injury, poisoning and procedural complications incl. 250 deaths
- 19,071 Investigations incl. 413 deaths
- 6,813 Metabolism and nutrition disorders incl. 300 deaths
- 107,976 Musculoskeletal and connective tissue disorders incl. 251 deaths
- 1,156 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 115 deaths
- 142,329 Nervous system disorders incl. 1,231 deaths
- 1,154 Pregnancy, puerperium and perinatal conditions incl. 13 deaths
- 149 Product issues incl. 3 deaths
- 14,434 Psychiatric disorders incl. 201 deaths
- 4,428 Renal and urinary disorders incl. 244 deaths
- 25,857 Reproductive system and breast disorders incl. 11 deaths
- 34,767 Respiratory, thoracic and mediastinal disorders incl. 1,337 deaths
- 45,736 Skin and subcutaneous tissue disorders incl. 118 deaths
- 3,412 Social circumstances incl. 46 deaths
- 11,812 Surgical and medical procedures incl. 228 deaths
- 17,353 Vascular disorders incl. 491 deaths
Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ Astra Zeneca – 9,667deaths and 1,388,494 injuries to 12/11/2022:
- 15,933 Blood and lymphatic system disorders incl. 360 deaths
- 24,615 Cardiac disorders incl. 1,012 deaths
- 298 Congenital familial and genetic disorders incl. 12 deaths
- 15,431 Ear and labyrinth disorders incl. 8 deaths
- 876 Endocrine disorders incl. 8 deaths
- 22,942 Eye disorders incl. 34 deaths
- 123,551 Gastrointestinal disorders incl. 511 deaths
- 376,016 General disorders and administration site conditions incl. 2,239 deaths
- 1,253 Hepatobiliary disorders incl. 91 deaths
- 7,141 Immune system disorders incl. 49 deaths
- 59,884 Infections and infestations incl. 818 deaths
- 15,929 Injury poisoning and procedural complications incl. 239 deaths
- 33,678 Investigations incl. 228 deaths
- 15,264 Metabolism and nutrition disorders incl. 150 deaths
- 201,842 Musculoskeletal and connective tissue disorders incl. 199 deaths
- 969 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 65 deaths
- 276,325 Nervous system disorders incl. 1,402 deaths
- 740 Pregnancy puerperium and perinatal conditions incl. 23 deaths
- 216 Product issues incl. 1 death
- 24,640 Psychiatric disorders incl. 88 deaths
- 5,020 Renal and urinary disorders incl. 107 deaths
- 18,719 Reproductive system and breast disorders incl. 3 deaths
- 48,116 Respiratory thoracic and mediastinal disorders incl. 1,271 deaths
- 60,805 Skin and subcutaneous tissue disorders incl. 81 deaths
- 2,537 Social circumstances incl. 11 deaths
- 3,529 Surgical and medical procedures incl. 45 deaths
- 32,225 Vascular disorders incl. 612 deaths
Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson – 3,234 deaths and 178,053 injuries to 12/11/2022:
- 1,794 Blood and lymphatic system disorders incl. 72 deaths
- 3,948 Cardiac disorders incl. 267 deaths
- 64 Congenital, familial and genetic disorders incl. 3 deaths
- 1,946 Ear and labyrinth disorders incl. 3 deaths
- 164 Endocrine disorders incl. 2 deaths
- 2,337 Eye disorders incl. 16 deaths
- 11,933 Gastrointestinal disorders incl. 129 deaths
- 49,033 General disorders and administration site conditions incl. 897 deaths
- 221 Hepatobiliary disorders incl. 23 deaths
- 848 Immune system disorders incl. 12 deaths
- 16,007 Infections and infestations incl. 273 deaths
- 1,699 Injury, poisoning and procedural complications incl. 38 deaths
- 8,184 Investigations incl. 171 deaths
- 1,142 Metabolism and nutrition disorders incl. 88 deaths
- 22,051 Musculoskeletal and connective tissue disorders incl. 74 deaths
- 160 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 14 deaths
- 30,257 Nervous system disorders incl. 317 deaths
- 135 Pregnancy, puerperium and perinatal conditions incl. 1 death
- 38 Product issues
- 2,651 Psychiatric disorders incl. 37 deaths
- 773 Renal and urinary disorders incl. 53 deaths
- 4,159 Reproductive system and breast disorders incl. 7 deaths
- 6,227 Respiratory, thoracic and mediastinal disorders incl. 405 deaths
- 5,438 Skin and subcutaneous tissue disorders incl. 17 deaths
- 718 Social circumstances incl. 8 deaths
- 1,332 Surgical and medical procedures incl. 104 deaths
- 4,794 Vascular disorders incl. 203 deaths
Total reactions for the COVID-19 vaccine NUVAXOVID(NVX-COV2373) from Novavax – 3 deaths and 3,987 injuries to 12/11/2022:
- 90 Blood and lymphatic system disorders
- 243 Cardiac disorders
- 0 Congenital familial and genetic disorders
- 56 Ear and labyrinth disorders
- 1 Endocrine disorders
- 82 Eye disorders
- 262 Gastrointestinal disorders
- 861 General disorders and administration site conditions incl. 1 death
- 5 Hepatobiliary disorders
- 41 Immune system disorders
- 205 Infections and infestations
- 43 Injury poisoning and procedural complications
- 107 Investigations
- 22 Metabolism and nutrition disorders
- 497 Musculoskeletal and connective tissue disorders
- 2 Neoplasms benign malignant and unspecified (incl cysts and polyps)
- 705 Nervous system disorders
- 2 Pregnancy puerperium and perinatal conditions
- 3 Product issues
- 67 Psychiatric disorders
- 21 Renal and urinary disorders
- 78 Reproductive system and breast disorders
- 204 Respiratory thoracic and mediastinal disorders incl. 1 death
- 255 Skin and subcutaneous tissue disorders
- 7 Social circumstances
- 34 Surgical and medical procedures
- 94 Vascular disorders incl. 1 death
*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms.
Sudden Deaths and Injuries Among Young and Formerly Healthy People Continue
24-Year-Old British Professional Athlete and Actress Genevieve Florence. (Left 2 image sources.)
Sudden deaths and injuries continue to be reported all across Europe and around the world, and more and more European politicians are beginning to speak out about how deadly the COVID-19 vaccines are.
But instead of halting these vaccines, the EMA has actually just approved a new COVID-19 vaccine by GSK and Sanofi.
After months of review at European regulators’ desks, GSK and Sanofi have scored a world-first nod to enter the COVID-19 vaccine market in Europe with their pandemic booster VidPrevtyn Beta.
Thursday, the European Commission signed off on the Sanofi-GSK booster to augment protection against COVID-19 in adults ages 18 and up, making VidPrevtyn the first next-gen, protein-based adjuvanted COVID-19 vaccine approved in Europe. (Full article.)
Australia has done the exact opposite, and has stated they are NOT approving new COVID-19 boosters for those under the age of 30 due to the high risks of heart disease from the shots.
The Australian government says the risk of myocarditis from a COVID booster might be greater than COVID itself — so it won’t allow people under 30 to get a fourth vaccine.
“In males aged 16-40 years, it is uncertain whether the risk following COVID-19 remains higher than the risk following vaccination,” the government said. (Full article.)
Here is the latest montage of young victims who have either suffered “sudden deaths” or crippling injuries. It starts with the testimony of 24-year-old British professional athlete and actress Genevieve Florence, who was mandated to get the shots to be able to continue filming, and totally disabled her.
This is on our Bitchute channel, and will also be on our Odysee and Telegram channels.
No comments:
Post a Comment